SES - Delayed Quote SGD

Clearbridge Health Limited (1H3.SI)

0.0100 0.0000 (0.00%)
At close: 3:29 PM GMT+8
Loading Chart for 1H3.SI
DELL
  • Previous Close 0.0100
  • Open 0.0110
  • Bid 0.0100 x --
  • Ask 0.0110 x --
  • Day's Range 0.0100 - 0.0110
  • 52 Week Range 0.0090 - 0.0310
  • Volume 330,300
  • Avg. Volume 620,711
  • Market Cap (intraday) 6.191M
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date Feb 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services. It also offers aesthetics, and dental and orthodontics services, as well as consultancy services for healthcare organization; and wholesales medicinal and pharmaceutical products. Clearbridge Health Limited was incorporated in 2010 and is based in Singapore.

www.clearbridgehealth.com

121

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 1H3.SI

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

1H3.SI
37.50%
STI Index
1.23%

1-Year Return

1H3.SI
65.52%
STI Index
0.50%

3-Year Return

1H3.SI
93.38%
STI Index
2.69%

5-Year Return

1H3.SI
94.51%
STI Index
2.09%

Compare To: 1H3.SI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1H3.SI

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    6.19M

  • Enterprise Value

    9.34M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.54

  • Price/Book (mrq)

    0.61

  • Enterprise Value/Revenue

    0.81

  • Enterprise Value/EBITDA

    -0.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -280.23%

  • Return on Assets (ttm)

    -7.26%

  • Return on Equity (ttm)

    -110.16%

  • Revenue (ttm)

    11.49M

  • Net Income Avi to Common (ttm)

    -32.2M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.13M

  • Total Debt/Equity (mrq)

    57.51%

  • Levered Free Cash Flow (ttm)

    -1.81M

Company Insights: 1H3.SI

People Also Watch